AU2010904033A0 - A modified release formulation for highly soluble active ingredients - Google Patents

A modified release formulation for highly soluble active ingredients

Info

Publication number
AU2010904033A0
AU2010904033A0 AU2010904033A AU2010904033A AU2010904033A0 AU 2010904033 A0 AU2010904033 A0 AU 2010904033A0 AU 2010904033 A AU2010904033 A AU 2010904033A AU 2010904033 A AU2010904033 A AU 2010904033A AU 2010904033 A0 AU2010904033 A0 AU 2010904033A0
Authority
AU
Australia
Prior art keywords
active ingredients
release formulation
modified release
highly soluble
soluble active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2010904033A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma International Pty Ltd
Original Assignee
Mayne Pharma International Pty Ltd
Filing date
Publication date
Application filed by Mayne Pharma International Pty Ltd filed Critical Mayne Pharma International Pty Ltd
Publication of AU2010904033A0 publication Critical patent/AU2010904033A0/en
Abandoned legal-status Critical Current

Links

AU2010904033A 2010-09-08 A modified release formulation for highly soluble active ingredients Abandoned AU2010904033A0 (en)

Publications (1)

Publication Number Publication Date
AU2010904033A0 true AU2010904033A0 (en) 2010-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
HUS2200018I1 (en) Pharmaceutical composition comprising drospirenone for use as a contraceptive
EP2643060A4 (en) Biodegradable fire-fighting formulation
WO2012084126A3 (en) Formulation of lacosamide
EP2637716A4 (en) Beneficial agent dispenser
ZA201209682B (en) Dry powder formulation comprising an antimuscarinic drug
EP2552212B8 (en) An improved formulation
GB2486567B (en) Pharmaceutical formulation
EP2595735A4 (en) Enhanced reel for agricultural mixer
EP2611847A4 (en) Amphiphile for solubilization of water-soluble active ingredients
WO2010114629A9 (en) Formulation
ZA201306643B (en) Formulation comprising phenylaminopyrimidine derivatives as active agent
WO2012074830A3 (en) Modified release tranexamic acid formulation
EP2542082B8 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol
EP2275087B8 (en) Prasugrel controlled release formulations
GB0918149D0 (en) Improved medicinal aerosol formulation
IL228462B (en) Film-forming composition for a ph-dependent sustained release of the active agent
HU1000444D0 (en) Process for the preparation of a pharmaceutical active ingredient
HK1187821A1 (en) A topical formulation comprising a corticosteroid as active ingredient
ZA201209038B (en) Adhesive slow-release formulations for the local administration of curcumin
AU2010904033A0 (en) A modified release formulation for highly soluble active ingredients
AU2011903692A0 (en) A modified release formulation for highly soluble active ingredients
IL222522A (en) Dietary formulation for slow release comprising a water soluble core comprising an active ingredient and an outer coating
EP2601974A4 (en) Pharmaceutical preparation for controlling water-soluble drug release
AU2013204097B2 (en) Pharmaceutical composition
AU2013204095B2 (en) Pharmaceutical composition